Invesco Pharmaceuticals ETF
PJP
PJP
101 hedge funds and large institutions have $134M invested in Invesco Pharmaceuticals ETF in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
42% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less call options, than puts
Call options by funds: $241K | Put options by funds: $668K
Holders
101
Holding in Top 10
1
Calls
$241K
Puts
$668K
Top Buyers
| 1 | +$6.06M | |
| 2 | +$2.24M | |
| 3 | +$2.03M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.74M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.7M |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$3.38M | |
| 3 | -$2.85M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.62M |
| 5 |
VF
Virtu Financial
New York
|
-$2.37M |